Andrew G. Muntean, Ph.D.
Department of Pathology
University of Michigan School of Medicine
7520B Medical Science Research Building I
1301 Catherine Street
Ann Arbor, MI 48109-5602
Phone: (734) 936-1467
Normal and malignant hematopoiesis | Learn More
Molecular and Cellular Pathology: PhD Program
Cancer Biology: cancerbio.medicine.umich.edu
Dr. Andrew Muntean has spent over ten years studying the molecular genetics and biochemical mechanisms governing aspects of normal and malignant hematopoiesis. He received his B.S. in Biology from Indiana University (Bloomington, IN) in 1999. He earned his Ph.D. in Molecular Genetics and Cell Biology from the University of Chicago (Chicago, IL) in 2006, studying transcriptional mechanisms governing hematopoiesis with Dr. John Crispino. Dr. Muntean completed postdoctoral training studying epigenetic and transcriptional mechanisms contributing to leukemia with Dr. Jay Hess at the University of Michigan (Ann Arbor, MI) in 2012.
In July of 2012, Dr. Muntean joined the faculty in the Department of Pathology at the University of Michigan as an Assistant Professor. In addition to his research interests, Dr. Muntean has actively trained undergraduate and graduate students, as well as post-doctoral fellows. He is involved in graduate level education and serves on the dissertation committees of several graduate students. He also serves on the graduate admissions committee for Molecular and Cellular Pathology within the Program in Biomedical Sciences (PIBS).
Dr. Muntean has received several awards including a Fellow Scholar Award in Basic Science from the American Society of Hematology, the Hollis Brownstein Research Award from the Leukemia Research Foundation and a Howard Temin Pathway to Independence Award in Cancer Research from the National Cancer Institute/National Institutes of Health. He also received a Research Scholar Award from the American Cancer Society. Dr. Muntean has served as a reviewer of several scientific journals and is a member of the American Society of Hematology.